Kaken Pharmaceutical Co., Ltd. (4521.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 156.95B |
| Enterprise Value | 116.09B |
| P/E Ratio | 67.17 |
| PEG Ratio | -0.4 |
| Price/Sales Ratio | 1.87 |
| Price/Book Ratio | 0.98 |
| Enterprise/Revenue | 1.34 |
| Enterprise/EBITDA | 18.12 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | -0.01 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 76.87B |
| Revenue/Share | 2,029.06 |
| Gross Profit | 39.24B |
| EBITDA | 5.68B |
| Net Income | 2.14B |
| Diluted EPS | 56.55 |
Balance Sheet
| Total Cash | 50.71B |
| Total Cash/Share | 1,338.39 |
| Total Debt | 3.85B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.52 |
| Book Value Per Share | 3,896.58 |
Price History
| 52-Week Change | -0.45 |
| 52-Week High | 4,445 |
| 52-Week Low | 3,540 |
| Moving Average 50 Days | 4,004.8 |
| Moving Average 200 Days | 3,986.93 |
Statistics
| Average Volume | 113,981 |
| Shares Outstanding | 37.87M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 190 |
| Trailing Annual Dividend Yield | 5 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | September 28, 2015 |
AD
